Table 2.
Knowledge of Pharmacotherapies by Substance Use History
| Full Sample | History of Illicit Substance Use |
No History of Illicit Substance Use |
χ2 (p=) | |
|---|---|---|---|---|
| Medication Name | n (%) | |||
| Brand Name | ||||
| Suboxone | 123 (39.2) | 80 (51.3) | 43 (27.2) | 19.08 (p<0.001) |
| Subutex | 71 (22.6) | 51 (32.7) | 20 (12.7) | 18.01 (p<0.001) |
| Vivitrol | 74 (23.6) | 45 (28.8) | 29 (18.4) | 4.78 (p=0.03) |
| Revia | 41 (13.1) | 27 (17.3) | 14 (8.9) | 4.93 (p=0.03) |
| Narcan | 156 (49.7) | 86 (55.1) | 70 (44.3) | 3.68 (p=0.06) |
| Methadone | 204 (65.0) | 106 (68.4) | 98 (62.0) | 1.40 (p=0.24) |
| Buprenorphine | 82 (21.7) | 61 (39.1) | 21 (13.3) | 27.10 (p<0.001) |
| Naltrexone | 68 (21.7) | 46 (29.5) | 22 (13.9) | 11.21 (p<0.001) |
| Naloxone | 84 (26.8) | 56 (35.9) | 28 (17.7) | 13.23 (p<0.001) |
Note. Chi-Square analyses were conducted to assess differences in knowledge of specific pharmacotherapies based on substance use history. Bolded text indicates significant difference between groups (those with a history of substance and those with no such history), p<0.05. Individuals with a history of substance use were more knowledgeable of all individual medications than those without a history of substance use, except for Narcan and Methadone, for which there were no group differences.